IgG1 and IgG2 are the predominant subclasses of antiphospholipid antibody in women with the lupus anticoagulant

We studied the sera of 36 patients with lupus anticoagulant and IgG antibodies against both phosphatidylserine and cardiolipin. Most sera also had IgG antibodies against other phospholipids: 97% against phosphatidylinositol, 91% against phosphatidylglycerol, and 82% against phosphatidylethanolamine. IgG2 was the predominant subclass against cardiolipin and phosphatidylserine; 35 of 36 patients (98%) had IgG2 against both phospholipids. Most patients also had the IgG1 subclass; 32 of 36 (89%) against cardiolipin and 25 of 36 (69%) against phosphatidylserine. IgG3 and IgG4 subclasses were present at very low concentrations and in only a minority of the sera. The antibody response against phosphatidylserine was characterized by significantly less IgG1 than was the response against cardiolipin (P less than 0.01), although the IgG2 responses against each phospholipid were not different. IgG subclasses were unrelated to any other aspect of the patients' history, including a history of thrombocytopenia or thrombosis, a positive antinuclear antibody test, or a diagnosis of systemic lupus erythematosus.     

Kinetics and magnitude of antibody responses against the conserved 47-kilodalton antigen and the variable 56-kilodalton antigen in scrub typhus patients

Western blot analysis of Orientia tsutsugamushi whole-cell lysates with scrub typhus patient sera has identified at least five protein antigens of O. tsutsugamushi with molecular sizes of 22 kDa, 47 kDa, 56 kDa, 58 kDa, and 110 kDa. In this study, sera from serial bleedings of 108 patients were used to study the kinetics and the magnitude of specific antibody responses against the 47-kDa and 56-kDa antigens. Recombinant protein of the conserved 47-kDa antigen (r47b) or a mixture of truncated 56-kDa antigen (r56s) from three prototype strains was used as the antigen in an enzyme-linked immunosorbent assay (ELISA). Our results showed that 76% and 93% of these patients had elevated IgM and IgG against r47b, respectively, and 98% and 100% had elevated IgM and IgG against r56s, respectively. The kinetics of antibody responses against r47b and r56s can be grouped into three patterns. In the first type of response, IgM and IgG against r47b and r56s appeared about the same time. The IgM and IgG titers against r56s were much higher than those against r47b. In the second type of response, induction of IgM appeared to be similar to that in the first type. The major difference to the first type is that the IgG titers against r47b were induced at least 1 week later than those against the r56s. The third type showed strong IgG responses against both r47b and r56s, and low or no IgM responses indicated a secondary infection. This is the first systematic investigation of antibody response kinetics against the conserved 47-kDa antigen versus the variable 56-kDa antigen in scrub typhus patients.     

Gifted and nongifted race and gender effects on item functioning on the Kaufman Assessment Battery for Children

This study examined differential item function on the K-ABC for gifted and nongifted subjects on the basis of race and gender using the technique for partial correlation proposed by Stricker (1982) and Reynolds, Willson, and Chatman (1984). It was determined that there were no items biased against gifted Black children and that 8 items were biased against gifted White children. Three items were found to be biased against nongifted Black children, while 4 items were biased against nongifted White children. When gender was considered, 2 items were found to be biased against gifted males, and 2 items also were found to be biased against gifted females. There were 10 items that were biased against nongifted Black males and 6 items biased against nongifted females. Systematic bias against race or gender was not found. It appears that the K-ABC is a relatively nonbiased test suitable for the evaluation of both gifted and nongifted children regardless of race or gender.     

Mothers' intentions and the immunization of their infants

One hundred and seventy-eight mothers who had recently been delivered were interviewed before discharge from hospital to ascertain their initial intentions about vaccination of their children. Nine months later the behaviour of 154 mothers was checked from health service records; 24 were lost to follow-up.

One hundred and forty-one (92 per cent) of the infants had received at least one dose of vaccine against polio, diphtheria and tetanus. Eighty-five infants (63 per cent of 135) had received at least one dose of vaccine against whooping-cough; 19 mothers had been advised against the vaccine. Failure to have their children vaccinated against whooping-cough correlated with the mothers' initial intentions, although a high proportion of mothers who were initially against the vaccine had started vaccination by the time their child was nine months old. Mothers attending general practitioners were more likely to have their infants vaccinated against whooping-cough than those attending community health clinics, and this difference was not explained by the social characteristics of the mothers nor by more positive early intentions among the mothers who attended general practitioners.

     

Activity of the cyclic depsipeptide emodepside (BAY 44–4400) against larval and adult stages of nematodes in rodents and the influence on worm survival

The present investigations deal with the activity of the cyclic depsipeptide emodepside (BAY 44-4400) against larval and adult stages of three rodent nematodes. While emodepside acts strongly against the adult stages of the rat nematodes Nippostrongylus brasiliensis and Strongyloides ratti, as well as against the mouse nematode Heligmosomoides polygyrus, its actions against the larval stages of these nematodes vary according to the species. Thus, emodepside is highly effective against the lung and intestine larval stages of N. brasiliensis and S. ratti. By contrast. the larval stages of H. polygyrus in the intestine are only partly affected by higher emodepside dosages.     

Reactions of immune sera against the nucleocapsid, envelope and whole herpes simplex virus type 1.

Antibodies against (a) naked particles, (b) virus envelope, and (c) whole herpes simplex virus (HSV) type 1 were investigated. Immune rabbit serum against naked particles (and formalized naked particles) contained virus neutralizing (VN) antibody in a low titre as compared to the titre of complement-fixing (CF) antibody. Immune rabbit serum against the viral envelope had similar titres of VN and CF antibodies. In gel double diffusion precipitation tests, whole HSV gave two precipitation zones with antibodies against naked particles two zones with antibodies against the virus envelope, several zones with antibodies against whole virus and two marked zones against human convalescent serum. Viral nucleocapsid reacted with two zones with antibodies against the nucleocapsid and a faint zone with antibodies against the virus envelope. The envelopes gave two zones with antibodies against whole virus and a faint zone with antibodies against naked particles. Human convalescent serum gave a single precipitation zone with viral nucleocapsid and two zones with virus envelope and whole virus.     

β2-Microglobulin on the Cell Surface. Relationship to HL-A Antigens and the Mixed Leucocyte Culture Reaction

Fab'-fragments derived from antibodies against β₂-microglobulin will completely abolish the cytotoxic effect of antibodies against HL-A serological determinants. This is the result of the Fab'-fragments competing with the antibodies against the HL-A antigens for binding to the lymphocyte surface. Reciprocally, it is shown that Fab'-fragments against the HL-A alloantigenic structures impeded the binding of Fab'-fragments to cell surface bound β₂-microglobulin.
Fab'-fragments against β₂-microglobulin inhibit considerably the mixed leucocyte culture reaction (MLR). The main effect is on the responding cells, whereas when the stimulating cells are treated with Fab'-fragments against β₂-microglobulin they do not (or, at most, only slightly) change their characteristics in the MLR. Fab'-fragments against immunoglobulin light chains do not influence the MLR significantly, whereas Fab'-fragments against HL-A antigens depress the response.
Fab'-fragments against β₂-microglobulin do not interfere with the mitogenic stimulation of PHA, whereas Fab'-fragments from the antiserum used in this study against HL-A8 reduced the mitogenic effect of PHA considerably.     

狂犬病患者中和抗体检测的意义与发病关系探讨

对有确诊依据的３９例狂犬病患者进行抗狂犬病中和抗体检测。血清总阳性率为９７．４４％（３８／３９），但在前驱期和兴奋期仅为３５．９０％（１４／３９），麻痹期为９４．６０％（３５／３７）。脑脊液总阳性率为４０％（６／１５），在前驱期和兴奋期为３３．３３％（４／１２），麻痹期为７５％（３／４）。所有患者均未得到保护而发病。研究提示，这种抗体是病程后期的免疫应答，抗体效价也有一个由低到高的过程，可作为狂犬病的诊断依据之一。它的出现可能加速病程，即称作“早期死亡现象”。     

Studies on passive transfer of anti-dextran and anti-egg albumin reactivity in the rat.

We were unable, passively, to transfer reactivity against dextran to the skin or peritoneal mast cells of non-dextran-reactive rats, by using serum or material eluted at pH 3 from mast cells of spontaneously dextran-reactive rats. When the dextran-reactive donor rats had also been immunized against egg albumin (EA) with pertussis vaccine (inducing IgE anti-EA antibody), passive sensitivity against EA (but not against dextran) could easily be transferred. The results indicated that the anti-dextran reactivity is not due to IgE antibody. Systemic reactions against dextran and EA differed in pattern, supporting the concept that the two substances acted through different mechanisms.     

Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes

We studied the in vitro protective activities of human immunoglobulin G1 (IgG1), IgG3, and IgM antibodies against group B meningococci by constructing sets of chimeric mouse-human antibodies (chIgG1, chIgG3, and chIgM, respectively) with identical binding regions against the P1.7 and P1.16 epitopes on PorA. This was done by cloning the V genes of three mouse hybridoma antibodies and subsequently transfecting vectors containing the homologous heavy- and light-chain genes into NSO cells. Cell clones secreting intact human chIgG1, chIgG3, or chIgM antibodies originating from three parent mouse antibodies were isolated. The functional affinities appeared to be similar for all human isotypes and surprisingly also for the pentameric chIgM antibody. chIgG1 exhibited greater serum bactericidal activity (SBA) than chIgG3, while chIgG3 was more efficient in inducing a respiratory burst (RB) associated with opsonophagocytosis than chIgG1 was. On the other hand, chIgM exhibited SBA similar to that of chIgG1, but it exhibited much higher RB activity than chIgG3 and chIgG1 exhibited. The antibodies against the P1.16 epitope were more efficient in terms of SBA than the antibodies against the P1.7 epitope were; thus, 10- to 40-fold-lower concentrations of antibodies against P1.16 than of antibodies against P1.7 were needed to induce SBA. On the other hand, antibodies against these epitopes were equally effective in inducing RB. Our results revealed differences in the functional activities of human chIgG1, chIgG3, and chIgM antibodies against meningococci, which might influence their protective effects against meningococcal disease.     

Parallel studies on the effect of anti-lymphocytic antibody on cell mediated and humoral antibody responses in the rat

The effect of prolonged treatment with anti-lymphocytic IgG raised in horses on cell mediated (homograft rejection) and humoral type immune responses has been investigated simultaneously in the same animal. The rejection of skin homografts precedes the development of circulating antibodies against alum precipitated bovine serum albumin but may follow the formation of agglutinating antibodies against sheep erythrocytes. High levels of antibodies against horse IgG are frequently detected prior to graft rejection.     

Amoebecide and trichomonacide activities of secnidazole in the laboratory]

A study of the experimental chemotherapeutic activity of secnidazole as compared to metronidazole is presented, including a summary of toxicity, metabolism, pharmacokinetic studies and preliminary results from clinical trials. Secnidazole is about twice as active as metronidazole against experimental amebiasis, equiactive against trichomoniasis, and possesses low toxicity. After oral administration to man, active concentrations in the blood persist much longer than in the case of metronidazole and notably longer than for tinidazole. In the clinic, its therapeutic activity against hepatic amebiasis seems to be at least equal to that of metronidazole; it appears also to be more active against acute intestinal amebiasis, and specially more effective against E. minuta and cyst carriers. Against vaginal trichomoniasis it was as effective as metronidazole after repeated administration for several days, and the percentage recovery rate was as high after one single dose as after daily administration. The digestive tolerance seems to be very satisfactory. In view of these findings, the advantages which secnidazole might possess over other 5-nitroimidazoles already in use for the treatment of amebiasis and trichomoniasis are discussed.     

Viruses and Bacteria in the Etiology of the Common Cold

Two hundred young adults with common colds were studied during a 10-month period. Virus culture, antigen detection, PCR, and serology with paired samples were used to identify the infection. Viral etiology was established for 138 of the 200 patients (69%). Rhinoviruses were detected in 105 patients, coronavirus OC43 or 229E infection was detected in 17, influenza A or B virus was detected in 12, and single infections with parainfluenza virus, respiratory syncytial virus, adenovirus, and enterovirus were found in 14 patients. Evidence for bacterial infection was found in seven patients. Four patients had a rise in antibodies against Chlamydia pneumoniae, one had a rise in antibodies against Haemophilus influenzae, one had a rise in antibodies against Streptococcus pneumoniae, and one had immunoglobulin M antibodies against Mycoplasma pneumoniae. The results show that although approximately 50% of episodes of the common cold were caused by rhinoviruses, the etiology can vary depending on the epidemiological situation with regard to circulating viruses. Bacterial infections were rare, supporting the concept that the common cold is almost exclusively a viral disease.     

Autoantibodies and Autoantigens in the Urine of SLE Patients

Autoantibodies against RNA polymerase I (RNAPI), DNA, La and ribosomal P proteins were detected in the urine of systemic lupus erythematosus (SLE) patients, many with normal protein excretion rates. In a number of cases, the antibodies were detectable in the urine but not the serum sample of the same patient. The presence and relative concentrations of the urinary autoantibodies correlated with disease activity. RNAPI antigens were detected in the urine of SLE patients by radioimmunoassay and immunoblotting using rabbit antisera prepared against the purified holoenzyme. Immunoaffinity purification of the rabbit anti-RNAPI with SLE urine proteins resulted in antibodies directed primarily against the largest RNAPI subunit (S1; 194?kDa). Antibodies prepared against recombinant fusion proteins representing the DNA binding regions of human RNAPI(S1) reacted with a 35?kDa SLE urinary protein, a putative fragment of RNAPI(S1). Ribosomal protein P0 was detected in SLE patients' urine by immunoblotting, using rabbit antiserum prepared against recombinant human P1 fusion protein. The relative quantities of urinary P0 correlated with disease status. Analysis of urinary autoantibodies and corresponding antigens in conjunction with analysis of serum autoantibodies may be of value for the purpose of monitoring disease activity.     

Autoantibodies and autoantigens in the urine of SLE patients

Autoantibodies against RNA polymerase I (RNAPI), DNA, La and ribosomal P proteins were detected in the urine of systemic lupus erythematosus (SLE) patients, many with normal protein excretion rates. In a number of cases, the antibodies were detectable in the urine but not the serum sample of the same patient. The presence and relative concentrations of the urinary autoantibodies correlated with disease activity. RNAPI antigens were detected in the urine of SLE patients by radioimmunoassay and immunoblotting using rabbit antisera prepared against the purified holoenzyme. Immunoaffinity purification of the rabbit anti-RNAPI with SLE urine proteins resulted in antibodies directed primarily against the largest RNAPI subunit (S1; 194 kDa). Antibodies prepared against recombinant fusion proteins representing the DNA binding regions of human RNAPI(S1) reacted with a 35 kDa SLE urinary protein, a putative fragment of RNAPI(S1). Ribosomal protein P0 was detected in SLE patients' urine by immunoblotting, using rabbit antiserum prepared against recombinant human P1 fusion protein. The relative quantities of urinary P0 correlated with disease status. Analysis of urinary autoantibodies and corresponding antigens in conjunction with analysis of serum autoantibodies may be of value for the purpose of monitoring disease activity.     

Antibodies against Hantaviruses in game and domestic oxen in the Czech Republic]

Using the test of indirect immunofluorescence, the authors examined sera of animals for antibodies against the strain CG 18-20 of Hantavirus (identical with strain Puumala) and against the Hantaan strain. As a control and supplement of the examination the authors used cells containing the TBE virus, strain Hypr. In a group of 260 hares (Lepus europaeus) in 3.5% antibodies were present against Hantavirus CG 18-20. Of 41 deer (Capreolus capreolus) they were present in 14.1%. Of 11 fallow-deers none had antibodies against hantaviruses. Among 145 specimens of Bos taurus antibodies were present in two incl. one against the strain Hantaan. The findings are discussed in relation to previous research of natural foci of hantavirus infections and infections with the TBE virus in Bohemia and Moravia. The paper reveals hitherto unknown localities of foci and hitherto not studied participants of the circulation of hantaviruses.     

Critical re-examination of the distribution of aromatase-immunoreactive cells in the quail forebrain using antibodies raised against human placental aromatase and against the recombinant quail, mouse or human enzyme

Mouse and quail aromatase cDNAs were isolated from libraries of mouse ovary and quail brain by using a human aromatase cDNA fragment (hA-24) as a probe. These three cDNAs were inserted into plasmid vectors and expressed in Escherichia coli. Antisera against these purified recombinant proteins were raised in rabbit and purified by ammonium sulfate fractionation and affinity chromatography. The three antibodies directed against recombinant human, mouse and quail proteins were used to visualize aromatase-immunoreactive cells in the quail brain. They were compared with the antibody raised against human placental aromatase used in previous experiments and with another antibody recently developed by similar methods. The signal obtained with all antibodies was completely abolished by preadsorption with the homologous recombinant antigens and the signal produced by the two antibodies raised against placental aromatase was similarly abolished by a preadsorption with recombinant quail aromatase. The antibodies raised against recombinant proteins identified the major groups of aromatase cells previously described in the quail brain. The antibodies directed against the mouse and quail antigen identified more positive cells and stained them more densely than the antibodies raised against human recombinant antigen or purified placental aromatase. The new cell groups identified by the antibody raised against quail recombinant aromatase were located in an area ventral to the fasciculus prosencephali lateralis, the nucleus accumbens, the paleostriatum ventrale, the nucleus taeniae, the area around the nucleus ovoidalis, the caudal tuber and the mesencephalic central gray. A critical re-examination of the distribution and nomenclature of the aromatase-positive cells is proposed based on these new findings.     

Genetic Vaccination of Mice with Plasmids Encoding the NS1 Non-structural Protein from Tick-borne Encephalitis Virus and Dengue 2 Virus

Although there is a safe, inexpensive and efficacious vaccine against yellow fever, vaccination against other flavivirus diseases is less successful. There is no licensed vaccine against dengue fever and current vaccines against tick-borne encephalitis (TBE) and Japanese encephalitis are expensive and require several injections. Furthermore novel vaccines containing only virus envelope proteins may raise fears over antibody mediated enhancement (ADE) of disease. Here we report the successful use of genetic vaccination against TBE in an experimental animal model using a plasmid containing the coding sequence of a non-structural protein (NS1). Such vaccines would provide inexpensive protection against disease, without raising concerns over inducing ADE on subsequent exposure to heterotypic infectious virus. Attempts to generate chaemeric plasmids to protect against both TBE and dengue fever were less successful. Although these chaemeric plasmids directed the synthesis and secretion of the virus NS1 protein normally, no protection was observed against either TBE or dengue fever.     

Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis

The development of protein-polysaccharide conjugate vaccines has had a major impact on Haemophilus influenzae type b disease. The application of this technology to Neisseria meningitidis is also striking, particularly for serogroup C. However, significant challenges exist for the development of vaccines against non-typeable H. influenzae and against N. meningitidis serogroup B. Issues such as non-vaccine-strain replacement and correlates of protection need to be addressed as well as the longer-term implications of vaccination against what are essentially 'normal' microflora.